← Leaderboards
Shabnam Shalapour
University Of California, San Diego
$909,188
Attributed
$3,636,750
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $737.5K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,636,750 · 1
By mechanism
U01$3,636,750 · 1
Top collaborators
- Anthony Boutros El-Khoueiry5 shared
- Michael Karin5 shared
- Hidekazu Tsukamoto5 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Michael Karin$60,628,305
- Alan R. Saltiel$35,794,253
- Christopher K Glass$71,096,171
- David A Brenner$18,624,596
- Chunru Lin$7,032,732
Others in their field
Other Emerging Leaders on “Etiology”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$35,120,637
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Vanessa Rivera-Amill · Ponce School Of Medicine$12,587,042
- Julie Stoner · University Of Oklahoma Hlth Sciences Ctr$12,318,552
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
Research focus
EtiologyAffectAdaptive Immune SystemAdaptive Immune ResponseAttenuatedCancer ControlCancer EtiologyCancer ImmunotherapyCell Adhesion MoleculesCessation Of LifeChemical CarcinogenChemokineChronic Liver InflammationClinical ResearchConduct Clinical TrialsCost SavingsCytotoxic T-LymphocytesDiffusionDoctor Of MedicineDoctor Of PhilosophyDoctor Of Veterinary MedicineDrug TargetingEffective TherapyEurope
Grant awards (5)
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2022 · AA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2021 · AA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,384
U01 · FY2020 · AA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,197
U01 · FY2019 · AA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$737,531
U01 · FY2018 · AA